Tyrosine phosphorylation of SHIP promotes its proteasomal degradation
Experimental Hematology, ISSN: 0301-472X, Vol: 38, Issue: 5, Page: 392-402.e1
2010
- 39Citations
- 61Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations39
- Citation Indexes39
- 39
- CrossRef36
- Captures61
- Readers61
- 61
Article Description
The activity of the SH2-containing-phosphatidylinositol-5′-phosphatase (SHIP, also known as SHIP1), a critical hematopoietic-restricted negative regulator of the PI3 kinase (PI3K) pathway, is regulated in large part via its protein levels. We sought to determine the mechanism(s) involved in its downregulation by BCR-ABL and by interleukin (IL)-4. We used Ba/F3 p210-tetOFF cells to study the downregulation of SHIP by BCR-ABL and bone marrow−derived macrophages to study SHIP's downregulation by IL-4. We show herein that BCR-ABL downregulates SHIP, but not SHIP2 or PTEN, and this can be blocked with the Src kinase inhibitor PP2, which inhibits the tyrosine phosphorylation of SHIP, or with the proteasomal inhibitor MG-132. We also show, using anti-SHIP immunoprecipitates, that c-Cbl and Cbl-b are associated with SHIP and that BCR-ABL induces SHIP's polyubiquitination. This ubiquitination can be blocked with PP2, consistent with the tyrosine phosphorylation of SHIP acting as a signal for its ubiquitination. In bone marrow−derived macrophages, IL-4 also leads to the proteasomal degradation of SHIP but, unlike in Ba/F3 p210-tetOFF cells, SHIP2 is also proteasomally degraded and the degradation of both inositol phosphatases can be prevented with PP2 or MG-132. Our results suggest that SHIP protein levels can be reduced via BCR-ABL and/or Src family member-induced tyrosine phosphorylation of SHIP because this triggers its polyubiquitination and degradation within the proteasome.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0301472X10001013; http://dx.doi.org/10.1016/j.exphem.2010.03.010; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77951454047&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/20304029; https://linkinghub.elsevier.com/retrieve/pii/S0301472X10001013
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know